Cardiomyopathy, arrhythmia, heart valve disease, and pulmonary hypertension
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: From January 1, 1990, patients diagnosed with cardiomyopathy, arrhythmia, heart valve disease, and pulmonary hypertension, which are considered hereditary diseases, at the Department of Cardiovascular Medicine, Cardiovascular Surgery, and Pediatrics, Nagasaki University Hospital. , their blood relatives who have given their consent.
Exclusion criteria
Exclusion criteria: Cardiomyopathy, arrhythmia disease, heart valve disease, and pulmonary hypertension that are not considered to be hereditary.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of genes and investigation of clinical pathology of cardiomyopathy, arrhythmia, heart valve disease, and pulmonary hypertension. | — |
Countries
Japan
Contacts
Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan Department of Cardiovascular Medicine